Share
 
Title
Code
Session Type
Venue
Date Time
Co-Chairs:
11:00
THAE0101
Introduction
Michael Ruffner, U.S. President's Emergency Plan for AIDS Relief (PEPFAR), United States

11:10
THAE0102
The implications of macroeconomic stability on achieving sustainable, domestic financing for HIV in Zambia
Thomas Fagan, Palladium, United States
Abstract
Slides

11:25
THAE0103
An HIV/AIDS investment case for Namibia: health impacts and resource needs for alternative program scale up packages over 2016-2030
Nana Poku, University of KwaZulu-Natal, South Africa
Michael Strauss, University of KwaZulu-Natal, South Africa
Abstract
Slides

11:40
THAE0104
Potential domestic source financing for scaled up antiretroviral therapy in 97 countries from 2015 to 2020
Catherine Barker, Palladium, United States
Abstract
Slides

11:55
THAE0105
Countries with concentrated epidemics among key populations still receive disproportionally lower PEPFAR COP funding than generalized epidemics
Laura Lazar, AVAC, United States
Abstract
Slides

12:10
THAE0106
HIV prevention research & development funding trends 2000-2015: tracking investment flows from research to rollout of new prevention technologies
Emily Donaldson, AVAC, United States
Abstract
Slides